Download
12936_2024_Article_5123.pdf 1,32MB
WeightNameValue
1000 Titel
  • The impact of the RTS,S malaria vaccine on uncomplicated malaria: evidence from the phase IV study districts, Upper East Region, Ghana, 2020–2022
1000 Autor/in
  1. Adjei, Michael Rockson |
  2. Okine, Rafiq |
  3. Tweneboah, Peter Ofori |
  4. Baafi, Janet Vanessa |
  5. Afriyie, Nana Akua |
  6. Teviu, Emmanuel Akwoulo Agyigewe |
  7. Nyuzaghl, Josephat Ana-Imwine |
  8. Dzotsi, Emmanuel Kofi |
  9. Ohene, Sally-Ann |
  10. Grobusch, Martin Peter |
1000 Verlag BioMed Central
1000 Erscheinungsjahr 2024
1000 Publikationstyp
  1. Artikel |
1000 Online veröffentlicht
  • 2024-10-10
1000 Erschienen in
1000 Quellenangabe
  • 23(1):305
1000 Copyrightjahr
  • 2024
1000 Lizenz
1000 Verlagsversion
  • https://doi.org/10.1186/s12936-024-05123-6 |
  • https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11466024/ |
1000 Publikationsstatus
1000 Begutachtungsstatus
1000 Sprache der Publikation
1000 Abstract/Summary
  • <jats:title>Abstract</jats:title><jats:sec> <jats:title>Background</jats:title> <jats:p>The RTS,S malaria vaccine has been prequalified for use in endemic settings prioritizing areas with moderate to high disease transmission. The impact of a vaccine at the population level may differ from observations during clinical trial due to programmatic, and individual-related factors, among others. The objective of this study was to assess the impact of the RTS,S malaria vaccine on uncomplicated malaria among children aged 12–59 months in the Phase IV study districts, Upper East Region, Ghana.</jats:p> </jats:sec><jats:sec> <jats:title>Methods</jats:title> <jats:p>A retrospective study was conducted using routine malaria surveillance data for the period 2020–2022. The burden of uncomplicated malaria was compared between the implementing (Kasena Nankana East and West districts) and comparator areas (Builsa North and South districts). The impact of RTS,S malaria vaccine was assessed by estimating the percentage reduction in uncomplicated malaria and incidence averted in the implementing area, accounting for the effect of confounders.</jats:p> </jats:sec><jats:sec> <jats:title>Results</jats:title> <jats:p>Over 50,000 episodes of uncomplicated malaria among children aged 12–59 months were included in the study. Uncomplicated malaria was reduced by 33% (95%CI 29–36) over the entire study period, but the malaria incidence averted declined from 324/1,000 (95% CI 298–339; p &lt; 0.0001) in 2020 to 287/1000 (95% CI 274–299; p &lt; 0.0001) in 2022.</jats:p> </jats:sec><jats:sec> <jats:title>Conclusion</jats:title> <jats:p>The RTS,S malaria vaccine significantly reduced the burden of uncomplicated malaria among children aged 12–59 months in the implementing area. The sequential marginal declines in malaria incidence averted over the study period might be due to waning of protective immunity and acquisition of natural immunity as children age. Strengthening uptake of the currently recommended vaccines and other malaria control interventions is required to improve public health impact.</jats:p> </jats:sec>
1000 Sacherschließung
lokal RTS,S
lokal Female [MeSH]
lokal Malaria/epidemiology [MeSH]
lokal Ghana
lokal Humans [MeSH]
lokal Malaria, Falciparum/epidemiology [MeSH]
lokal Malaria Vaccines/immunology [MeSH]
lokal Incidence [MeSH]
lokal Retrospective Studies [MeSH]
lokal Routine surveillance data
lokal Malaria, Falciparum/prevention
lokal Ghana/epidemiology [MeSH]
lokal Malaria vaccine
lokal Infant [MeSH]
lokal Male [MeSH]
lokal Kasena Nankana disticts
lokal Malaria/prevention
lokal Research
lokal Malaria Vaccines/administration
lokal Uncomplicated malaria
lokal Child, Preschool [MeSH]
1000 Fächerklassifikation (DDC)
1000 Liste der Beteiligten
  1. https://frl.publisso.de/adhoc/uri/QWRqZWksIE1pY2hhZWwgUm9ja3Nvbg==|https://frl.publisso.de/adhoc/uri/T2tpbmUsIFJhZmlx|https://frl.publisso.de/adhoc/uri/VHdlbmVib2FoLCBQZXRlciBPZm9yaQ==|https://frl.publisso.de/adhoc/uri/QmFhZmksIEphbmV0IFZhbmVzc2E=|https://frl.publisso.de/adhoc/uri/QWZyaXlpZSwgTmFuYSBBa3Vh|https://frl.publisso.de/adhoc/uri/VGV2aXUsIEVtbWFudWVsIEFrd291bG8gQWd5aWdld2U=|https://frl.publisso.de/adhoc/uri/Tnl1emFnaGwsIEpvc2VwaGF0IEFuYS1JbXdpbmU=|https://frl.publisso.de/adhoc/uri/RHpvdHNpLCBFbW1hbnVlbCBLb2Zp|https://frl.publisso.de/adhoc/uri/T2hlbmUsIFNhbGx5LUFubg==|https://frl.publisso.de/adhoc/uri/R3JvYnVzY2gsIE1hcnRpbiBQZXRlcg==
1000 Hinweis
  • DeepGreen-ID: 5581d9a6a1b84f49b69b5b4af09e8db3 ; metadata provieded by: DeepGreen (https://www.oa-deepgreen.de/api/v1/), LIVIVO search scope life sciences (http://z3950.zbmed.de:6210/livivo), Crossref Unified Resource API (https://api.crossref.org/swagger-ui/index.html), to.science.api (https://frl.publisso.de/), ZDB JSON-API (beta) (https://zeitschriftendatenbank.de/api/), lobid - Dateninfrastruktur für Bibliotheken (https://lobid.org/resources/search) ;
1000 Label
1000 Dateien
1000 Objektart article
1000 Beschrieben durch
1000 @id frl:6521411.rdf
1000 Erstellt am 2025-07-06T07:44:07.189+0200
1000 Erstellt von 322
1000 beschreibt frl:6521411
1000 Zuletzt bearbeitet 2025-08-04T09:46:14.415+0200
1000 Objekt bearb. Mon Aug 04 09:46:14 CEST 2025
1000 Vgl. frl:6521411
1000 Oai Id
  1. oai:frl.publisso.de:frl:6521411 |
1000 Sichtbarkeit Metadaten public
1000 Sichtbarkeit Daten public
1000 Gegenstand von

View source